Thromboembolic Events in Patients with HER2-Negative, Hormone Receptor-Positive, Metastatic Breast Cancer Treated with Ribociclib Combined with Letrozole or Fulvestrant: A Real-World Data
暂无分享,去创建一个
H. Abdel-Razeq | O. Salama | H. Abdulelah | Omar Khader | Baha’ Sharaf | Rama Almasri | Rashid H. Abdel-Razeq | Faris Tamimi | Mahmoud Abunasser | Sarah Edaily